Newsroom
October 14, 2022
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago Full Launch of BoneScalpel® Access™ at NASS DURHAM, NC –…
July 12, 2022
Bioventus Completes CartiHeal Acquisition
Bioventus Completes CartiHeal Acquisition DURHAM, NC – July 12, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader…
June 21, 2022
Bioventus Amends CartiHeal Acquisition Structure
Bioventus Amends CartiHeal Acquisition Structure DURHAM, NC – June 21, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global…
April 4, 2022
Bioventus Exercises Call Option to Acquire CartiHeal
DURHAM, NC – April 4, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
March 1, 2022
Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device
Industry Leading Peripheral Nerve Stimulator Upgraded to Improve Patient User Experience with Control of their Unique Chronic Pain Condition, Longer…
March 1, 2022
Bioventus Appoints Mark Singleton as Chief Financial Officer
DURHAM, NC – February 28, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…
January 11, 2022
Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue
DURHAM, NC – January 11, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…
December 28, 2021
Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference
DURHAM, NC – December 28, 2021 – Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali,…
December 21, 2021
Bioventus Appoints Michelle McMurry-Heath to Board of Directors
DURHAM, NC – December 21, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
December 20, 2021
Bioventus Receives US FDA Clearance for BoneScalpel® Access™
DURHAM, NC – December 20, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…
